DoH, Hayat Biotech collaborate to enhance pharmaceutical industry in emirate

ABU DHABI, 16th January, 2023 (WAM) — Hayat Biotech, a joint venture between G42 and Chinese pharmaceutical group Sinopharm CNBG, and the Department of Health – Abu Dhabi (DoH) have signed a declaration of collaboration aimed at strengthening the emirate’s efforts in R&D, clinical research, and its manufacturing capabilities. The collaboration comes in line with DoH’s ongoing efforts to elevate Abu Dhabi’s position as a hub for research and innovation in life sciences and a pioneering healthcare destination globally.In the presence of Abdulla bin Mohamed…

No Byline Policy

Editorial Guidelines

Corrections Policy

Source